Literature DB >> 20507777

Human infection with lymphocytic choriomeningitis virus.

Leslie L Barton.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20507777      PMCID: PMC3086242          DOI: 10.3201/eid1606.100250

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: I read with great interest the article regarding lymphocytic choriomeningitis virus (LCMV) meningitis in a New York City resident (). The authors’ conclusion that there is a need to ascertain the true incidence of LCMV infection is worthy of underscoring. Nearly 15 years ago, in this same journal, we described congenital LCMV as an unrecognized teratogen and recommended further “research to define the frequency of LCMV” (). Five years later, we reiterated that recommendation when reporting acquired LCMV meningoencephalitis in an adolescent from Tucson, Arizona (). Despite, or because of, the lack of prospective studies, the fact that this author has accrued data regarding >60 congenitally infected infants from all geographic areas in the United States during the past 15 years reinforces the concept that LCMV is a neglected pathogen whose time for more extensive study has indeed come.
  3 in total

1.  Lymphocytic choriomeningitis virus: an unrecognized teratogenic pathogen.

Authors:  L L Barton; C J Peters; T G Ksiazek
Journal:  Emerg Infect Dis       Date:  1995 Oct-Dec       Impact factor: 6.883

2.  Lymphocytic choriomeningitis virus: reemerging central nervous system pathogen.

Authors:  L L Barton; N J Hyndman
Journal:  Pediatrics       Date:  2000-03       Impact factor: 7.124

3.  Lymphocytic choriomeningitis virus meningitis, New York, NY, USA, 2009.

Authors:  Deborah S Asnis; Owen Muana; Do Gyun Kim; Minerva Garcia; Pierre E Rollin; Sally Slavinski
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

  3 in total
  1 in total

1.  Exposure to lymphocytic choriomeningitis virus, New York, USA.

Authors:  Barbara Knust; Adam Macneil; Susan J Wong; P Bryon Backenson; Aridth Gibbons; Pierre E Rollin; Stuart T Nichol
Journal:  Emerg Infect Dis       Date:  2011-07       Impact factor: 6.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.